Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900
Debt
Debt-to-Equity Ratio1.69
Current Ratio1.59
Quick Ratio1.44
Price-To-Earnings
Trailing P/E Ratio-20.83
Forward P/E Ratio-31.82
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.34 billion
Price / Sales0.64
Cash Flow$0.3163 per share
Price / Cash55.33
Book Value$27.41 per share
Price / Book0.64
Profitability
EPS (Most Recent Fiscal Year)($0.84)
Net Income$-52,980,000.00
Net Margins-5.56%
Return on Equity-1.67%
Return on Assets-0.48%
Miscellaneous
Employees10,600
Outstanding Shares48,900,000
Market Cap$870.46 million
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners declared that its Board of Directors has approved a stock buyback program on Saturday, December 16th 2017, which allows the company to buyback $50,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its stock is undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners Inc (NASDAQ:SGRY) posted its quarterly earnings data on Thursday, August, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.25) by $0.07. The firm had revenue of $444.78 million for the quarter, compared to the consensus estimate of $428.50 million. Surgery Partners had a negative net margin of 5.56% and a negative return on equity of 1.67%. The business's revenue was up 54.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.09) EPS. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What price target have analysts set for SGRY?
7 brokers have issued 12 month price targets for Surgery Partners' shares. Their forecasts range from $15.00 to $25.00. On average, they anticipate Surgery Partners' share price to reach $19.3333 in the next year. This suggests a possible upside of 10.5% from the stock's current price. View Analyst Price Targets for Surgery Partners.
What is the consensus analysts' recommendation for Surgery Partners?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.
Who are some of Surgery Partners' key competitors?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 47)
- Mr. Dennis Dean, Sr. VP & Corp. Controller (Age 46)
- Mr. Clifford G. Adlerz, Consultant & Director (Age 64)
- Ms. Teresa F. Sparks, Consultant (Age 49)
- Mr. Wayne Scott DeVeydt, CEO & Director (Age 48)
Has Surgery Partners been receiving favorable news coverage?
News articles about SGRY stock have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Surgery Partners earned a news impact score of 0.01 on Accern's scale. They also gave media coverage about the company an impact score of 46.88 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View Recent Headlines for Surgery Partners.
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include NN Investment Partners Holdings N.V. (11.29%), BlackRock Inc. (2.74%), Royce & Associates LP (1.99%), AMI Asset Management Corp (1.39%), Redmile Group LLC (1.27%) and Dimensional Fund Advisors LP (1.17%). Company insiders that own Surgery Partners stock include HIG Surgery Centers, Llc and Jennifer Baldock. View Institutional Ownership Trends for Surgery Partners.
Which major investors are selling Surgery Partners stock?
SGRY stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Soros Fund Management LLC, AMI Asset Management Corp, Point72 Asset Management L.P., Royce & Associates LP, BNP Paribas Arbitrage SA, Sei Investments Co. and Cim Investment Mangement Inc.. View Insider Buying and Selling for Surgery Partners.
Which major investors are buying Surgery Partners stock?
SGRY stock was acquired by a variety of institutional investors in the last quarter, including Redmile Group LLC, NN Investment Partners Holdings N.V., Highland Capital Management LP, Wolverine Asset Management LLC, BlackRock Inc., Millennium Management LLC, Dimensional Fund Advisors LP and Strs Ohio. View Insider Buying and Selling for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $17.50.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $870.46 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
